Puma Biotechnology appoints Alessandra Cesano to Board of Directors

PUMA BIOTECHNOLOGY, INC.

Dr. Cesano appointed effective July 29, 2022, also to R&D Committee.
She has served as CMO of ESSA Pharmaceuticals since 2019, previously CMO at NanoString.
Received option to purchase 100,000 shares at $2.93/share, vesting over 3 years.
Term expires at 2023 Annual Meeting; standard director compensation.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Alessandra Cesano

Director

PBYI · PUMA BIOTECHNOLOGY, INC.

Effective: 2022-07-29
Filed: August 2, 2022, 7:59 PM ET

On July 29, 2022, Alessandra Cesano, 62, was appointed to the Board of Directors (the “Board”) of Puma Biotechnology, Inc. (the “Company”), effective July 29, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Alessandra Cesano was appointed as Director at PUMA BIOTECHNOLOGY, INC..

Action: appointed
Role: Director

Exact text from the filing

On July 29, 2022, Alessandra Cesano, 62, was appointed to the Board of Directors (the “Board”) of Puma Biotechnology, Inc. (the “Company”), effective July 29, 2022.

View on SEC.gov

PUMA BIOTECHNOLOGY, INC. filing history →

Source: SEC EDGAR

accession 0001437749-22-018452

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.